Title : Polyamine Biosynthetic Pathway as a Drug Target for Osteosarcoma Therapy.

Pub. Date : 2018 Aug 16

PMID : 30115881






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In other pediatric cancer models, inhibition of the PA biosynthesis pathway with ornithine decarboxylase (ODC) inhibitor alpha-difluoromethylornithine (DFMO) results in decreased cell proliferation and differentiation. Eflornithine ornithine decarboxylase 1 Homo sapiens
2 In other pediatric cancer models, inhibition of the PA biosynthesis pathway with ornithine decarboxylase (ODC) inhibitor alpha-difluoromethylornithine (DFMO) results in decreased cell proliferation and differentiation. Eflornithine ornithine decarboxylase 1 Homo sapiens
3 In other pediatric cancer models, inhibition of the PA biosynthesis pathway with ornithine decarboxylase (ODC) inhibitor alpha-difluoromethylornithine (DFMO) results in decreased cell proliferation and differentiation. Eflornithine ornithine decarboxylase 1 Homo sapiens
4 In other pediatric cancer models, inhibition of the PA biosynthesis pathway with ornithine decarboxylase (ODC) inhibitor alpha-difluoromethylornithine (DFMO) results in decreased cell proliferation and differentiation. Eflornithine ornithine decarboxylase 1 Homo sapiens